Nina Haarup Ravn1, Inger Havsteen2, Jonas Peter Eiberg3,4,5
1Afdeling for Hjerne- og Nervesygdomme, Københavns Universitetshospital - Rigshospitalet.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Immunotherapy shows promise for colorectal cancer (CRC), particularly in mismatch-repair deficient (dMMR) cases. Pre-operative immunotherapy yields high response rates in dMMR CRC, with ongoing research into new combinations.
Area of Science:
Background:
Conclusions: